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Ischemic pain threshold and tolerance levels using the tourniquet pain technique 
and electrical cutaneous pain thresholds were measured in patients with 
asymptomatic ischemic heart disease. Thirty asymptomatic patients, who repeatedly 
exhibited no angina pectoris pain during the occurrence of exercise-induced coronary 
ischemia (2 0.1 mV ST segment depression in exercise ECG) were compared to 30 
randomly selected symptomatic control patients. In a smaller patient group (6 
symptomatic, 6asympatomatic) the degree of forearm ischemia during the tourniquet 
test was determined non-invasively by monitoring transcutaneous PO,. Results 
indicated that asymptomatic patients needed significantly more time to reach pain 
threshold following occlusion of forearm blood flow and exhibited significantly 
lower tcp02 values at threshold than symptomatic patients. Electrical pain thresholds 
were also elevated in the asymptomatic group. These findings indicate that the 
phenomenon of asymptomatic myocardial ischemia can be explained by an ex- 
tracardiac pain modifying mechanism. 
Introduction 
Among patients with coronary heart disease, a small group has been found that is 
of interest to pain research. These patients have objective signs of severe ischemic 
’ Part of these findings were presented at the IV World Congress on Pain, Seattle, WA, U.S.A., August, 
1984. 
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heart disease, but fail to experience angina pectoris pain. This phenomenon is 
referred to as asymptomatic myocardial ischemia. Although it has been known for 
some time that myocardial infarction can occur silently, more recently an increasing 
number of reports suggest that transient myocardial ischemia may also occur 
without pain [4,6,15]. Cohn [S] has described this as a defective angina1 pain 
warning system that would normally signal the patient to stop activity. This lack of 
pain is of considerable importance for the prognoses of these patients, i.e., especially 
in cases of sudden cardiac death [lo]. 
An explanation for this absence of pain in patients with asymptomatic myocar- 
dial ischemia remains equivocal. The aim of our study was to explore whether a 
general h~osensibility to pain may be responsible for this faulty warning system. 
We further asked whether endorphins play a role in the pain modification exhibited 
in these patients. 
(1) By exercising the forearm after arterial occlusion, we measured the duration 
of work necessary to elicit an ischemic pain response (threshold) and that needed to 
reach tolerance levels in symptomatic and asymptomatic patients with proved 
myocardial ischemia. 
(2) A possible explanation put forth for the lack of angina pectoris in 
asymptomatic myocardial ischemia suggests that these patients may not obtain the 
levels of ischemia during exercise that symptomatic patients do and that this lower 
ischemic level is insufficient to elicit angina pectoris pain. To test whether 
asymptomatic patients differ in their tissue oxygen metabolism, we measured the 
transcutaneous partial oxygen tension 112,201 in the occluded forearm by employing 
a non-invasive polarographic oxygen sensor. This measure provides information 
concerning the oxygen supply and demand in the resting and working muscle. 
Following arterial occlusion, the development of ischemia and anoxia in the 
working forearm can thus be quantitatively assessed [see also 81. 
(3) To test whether differences in pain thresholds were specific to ischemic pain, 
we measured thresholds for perceiving pain induced by electrical stimulation of the 
dermis following the method introduced by Notermans j22]. 
(4) To investigate the possible role of endogenous opioids (e.g., endorphins) in 
asymptomatic myocardial ischemia, we retested some of our asymptomatic patients 
on exercise ECG after injection of the opioid antagonist naloxone. The occurrence 
of pain during exercise following naloxone injection would suggest that such 
endogenous opioids might play a role in the absence of angina pectoris in patients 
with asymptomatic myocardial ischemia. 
Method 
Ethical approval and informed consent 
The study was approved by the ethical board at the Rehabilitation Clinic in Bad 
Krozingen. At least 1 day before participating in the experiments, patients were 
given a written explanation of the general research aims and possible hazards 
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involved and were then requested to sign an informed consent, which was complied 
to in all cases. 
Subjects 
Subjects were 60 male patients (mean age 51 + 7.2 years) with severe ischemic 
heart disease. 
(1) All patients demonstrated severe coronary artery disease (Z 75% stenosis in at 
least one major coronary vessel) as determined angiographically. 
(2) All patients exhibited substantial ST segment depression (2 0.1 mV in ECG) 
during several exercise conditions, thus representing an objective sign of transient 
myocardial ischemia. 
(3) A total of 27 patients in the asymptomatic and 27 patients in the symptomatic 
group demonstrated a pathologically high pulmonary capillary pressure during 
exercise as measured by floating catheter, thus giving another objective sign of 
exercise-induced transient myocardial ischemia. 
Patients were divided into one of two groups depending on the occurrence of 
self-reported pain during exercise ECG: 30 patients demonstrated symptomatic 
myocardial ischemia, i.e., the simultaneous occurrence of objective signs of myocar- 
dial ischemia and angina pectoris and 30 patients exhibited asymptomatic myocar- 
dial ischemia. These asymptomatic patients experienced no pain during the different 
exercise tests, although severe myocardial ischemica could be objectively shown. Of 
these 30 patients, 24 also reported no angina pectoris during everyday life, the 
remaining six had only mild symptoms. A total of 25 of these patients exhibited 
electrocardiographic evidence of previous myocardial infarction. In five of these 
patients, infarction occurred silently (i.e., no notice of infarction). Another seven of 
these patients noticed their infarction due to nausea or fatigue, but experienced no 
chest pain. 
Procedures 
In experiments 1 and 2, ischemic pain thresholds and tolerance levels were 
recorded in patients by employing a modified version of the tourniquet technique, 
first introduced by Smith et al. [26]. Here, we requested our patients to engage with 
their non-preferred hand a hand-grip dynamometer at a rate of 40 beats/mm. 
Exercise was performed until pain tolerance levels were reached. Ethical considera- 
tions led us to choose this form of the tourniquet technique, because the overall 
duration of the test was much shorter than with submaximal effort. Furthermore, 
the maximal effort technique was very similar to the exercise ECG tests performed 
clinically by the patients. In 4 symptomatic and in 3 asymptomatic, exercise was 
discontinued due to fatigue. In such cases, the cuff remained inflated and patients 
were asked to wait until tolerance was reached. Prior to engaging in this exercise, the 
cuff of a manometer was manually inflated to 170 mm Hg (all patients had systolic 
blood pressure below 150 mm Hg), thereby completely occluding arterial flow to the 
forearm. The tcpOz electrode used in experiment 2 further assured us that no 
leakage took place. After the cuff was fully inflated patients were asked to begin the 
hand-grip exercise. Patients were requested to report the following: 
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(a) The time when pain was first perceived in the working forearm, We refer to 
this as the duration threshold. 
(b) The time when the perceived pain became so intense that they could no 
longer tolerate it. We refer to this as the tolerance level. 
In experiment 1 (30 symptomatic and 30 asymptomatic patients) the time 
elapsing between the start of stimulation to the (a) threshold and (b) tolerance levels 
was recorded. 
In experiment 2 (in a randomly selected subgroup of 6 symptomatic and 6 
asymptomatic patients) transcutaneous partial oxygen tension (tcp0,) and skin 
blood flow (using heat clearance rate) were non-invasively monitored during the 
ischemic test using the Oxymonitor (Hellige Co.). This instrument consists of a 
polarographic sensor that is positioned on the skin surface of the forearm. The 
sensor has 3 polarograp~c cathodes that are submerged in electrolyte, all of which 
are covered with a Teflon membrane. A change in the amount of reduced oxygen in 
the electrolyte elicits a corresponding change in the potentials of these cathodes. The 
sensor is heated to 44°C thus eliciting hyperemia in the cutaneous tissue directly 
below the sensor. This provides a sufficient supply of oxygen in healthy cutaneous 
tissue so that in resting tcp0, approaches arterial p0, [20]. Heart rate and 
respiration were simultaneously recorded. The time elapsing to threshold and 
tolerance levels was also assessed. 
In experiment 3, electrical pain thresholds were determined by the Notermans 
procedure [22] at 3 sites on the left thigh using 10 incremental and 10 decremental 
staircase measurements per site. The electrode was positioned immediately above 
the skin surface, upon which electrolyte paste had been applied. Electrical impulses 
were given for 5 msec with an interstimulus interval of 5 sec. Patients responsed in a 
forced-choice paradigm whether they detected the impulse (i.e.. pricking pain) or 
not. Skin resistance was simultaneously controlled. Average threshold values are 
based on the mean of 60 trials per subject. The Notermans procedure was preferred 
over other forms of electrical stimulation (i.e., tooth pulp stimulation), because, for 
our heart patients, we wanted a method that appeared the least hazardous. 
In experiment 4, 10 of our 30 asymptomatic patients were randomly selected to 
perform exercise ECG after intravenous injection of 2 mg of the morphine antagonist 
naloxone. Injection was given immediately before the exercise test. As a placebo 
control, these patients were examined after injection of the same volume of saline. 
Naloxone and placebo injections were given in random order on a double-blind 
basis. 
Results 
All patients were administered a detailed neurologic examination including a 
tactile sensibility test using von Frey’s hairs on different areas of the body surface. 
We did not find any differences on neurologic variables between these two groups. 
There was no evidence that would suggest pol~europathy, e.g., such as history of 
higher alcohol consumption or influence of toxic substances, diabetic polyneuropa- 
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TABLE I 
COMPARISON OF SELECTED MEDICAL VARIABLES IN PATIENTS WITH SYMPTOMATIC 
AND ASYMPTOMATIC MYOCARDIAL ISCHEMIA 
ns = not significant. 
Myocardial ischemia 
Symptomatic 
(n = 30) 
l-vessel disease 
2-vessel disease 
3-vessel disease 
Friesinger score 
Ejection fraction (W) 
Heart volume (ml) 
Heart volume/body weight (ml/kg) 
Previous myocardial infarction 
10 
7 x=2.1 
13 i 
9.1& 2.9 
58 f 14 
814 f141 
10.8* 1.2 
23 
Asymptomatic 
(n = 30) 
P 
4 
10 w = 2.4 
16 I 
10.5+ 2.6 
57 + 12 
861 +215 
11.3+ 2.4 
25 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
TABLE II 
COMPARISON ON EXERCISE ECG VARIABLES BETWEEN SYMPTOMATIC (n = 30) AND 
ASYMPTOMATIC (n = 30) PATIENT GROUPS 
ns = not significant. 
Myocardial ischemia 
Symptomatic Asymptomatic P 
Rest 
Ischemia 
Maximal 
effort 
Heart rate 
Blood pressure Syst. 
Diast. 
Watts 
Heart rate 
Blood pressure 
Double product 
Syst. 
Diast. 
Watts 
Heart rate 
Blood pres- 
sure 
Double product 
ST segment 
depression (mv) 
No. of leads * 
with ST segment 
depression 
Syst. 
Diast. 
70 f 11 
139 &- 21 
87 f 8 
43 f 35 
103 f 16 
170 f 25 
loo f 10 
18014 k4798 
74 f 30 
120 f 16 
184 f 26 
103 * 11 
21817 k5090 
0.21 f 0.09 
3.4 f 1.8 
74* 11 ns 
135* 10 ns 
87&- 8 ns 
33* 19 
104+ 15 
159+ 16 
99+ 15 
17001+3480 
ns 
ns 
IIS 
ns 
ns 
71k 38 
122k 36 
175k 24 
103* 11 
21768 + 6 242 
ns 
ns 
ns 
ns 
ns 
0.39 f 0.15 
4.8 f 1.8 
0.001 
0.02 
* Of a total of 12 leads. 
thy, or differences in tactile thresholds. No general innate insensibility was evident 
in these patients. All patients could experience pain and showed no signs of (obvious 
neurologic deficits. 
Table I presents the cardiologic data for these two patient groups. As is evident 
in the table, no significant differences were found between the patient groups on 
severity of coronary heart disease (l-, 2- and 3-vessel disease, the Friesinger score), 
ejection fraction, heart volume, heart volume related to body weight, and previous 
infarction. Also in standard coronary risk factors (i.e., age, smoking, hypertension, 
diabetes, cholesterol and triglyceride level), no significant difference was found 
between patient groups. In the symptomatic group, diabetes was present in 3 
patients and in the asymptomatic group in 2 patients. 
Table II shows the results of exercise ECG (supine bicycle ergometer). The only 
differences evident between our patient groups indicate that myocardial ischemia 
was more substantial in the asymptomatic group. ST segment depression was 
slightly more pronounced and occurred in more leads in the asymptomatic group. 
Extraneous factors that could have caused false positive ST segment depression (i.e., 
digitalis medication, hypopotassium levels, myocardial hypertrophy, valvular dis- 
case) or that could have influenced coronary is&hernia and angina (medication, 
nitrates, beta-blockers, calcium antagonists) were controlled for. 
The results of our first experiment are depicted in Fig. 1. Asymptomatic patients 
exhibited higher ischemic pain threshold and pain tolerance levels than did symp- 
tomatic patients; both values are statistically significant (t tests: t = 2.64, df= 58, 
P < 0.01; t = 1.75, df = 58, P < 0.05, one-tailed). For the symptomatic patients 
ischemic pain occurred after an average of 70.4 set, while asymptomatic patients 
first reported pain after an average of 99.7 sec. 
Fig. 1. Group differences on time needed to reach threshold and tolerance during the ischemic pain test. 
Results of I tests shown for (n = 30) symptomatic and (n = 30) asymptomatic patients. Error bars show 
rt 1 standard error of mean. 
Experiment 2 
Fig. 2 presents the mean values for tcp0, (upper trace) and heart rate (lower 
trace) for symptomatic (dashed lines) and asymptomatic (solid lines) groups. As is 
evident in Fig. 2, the asymptomatic patients exhibited lower tcp0, levels at 
threshold and tolerance and needed more time to reach threshold and tolerance 
levels than do symptomatic patients. 
Fig. 3 shows these differences in the form of histograms. On the left half of Fig. 
3A, the mean values (rf 1 SE.) for tcp0, at threshold and tolerance levels are shown 
for the symptomatic (blank column) and asymptomatic (hatched column) groups. 
On the right side of Fig. 3B, the time elapsing from the start of the task to threshold 
and tolerance levels is also depicted for both patient groups. Though not depicted in 
Fig. 3, no significant differences were found for mean recovery time (defined as the 
time needed to regain the prestimulation baseline values for tcpOz) or for initial 
tcp0, baseline values, suggesting that normal blood flow and tissue p0, levels were 
comparable between patient groups. 
Significant differences (t tests, t = 2.25, df= 10, P < 0.05) were found for the 
time needed to reach threshold level and for the tcpOz values at threshold (t = 2.69, 
df= 10, P -c 0.05). Though substantial, the differences in tolerance levels (t = 2.02, 
df = 10, P < 0.07 and t = 2.09, u”= 10, P < 0.06, for tcpO* and work duration, 
respectively) did not obtain customary significance levels. This is probably due to 
our small sample size (n = 12) for this experiment. The time needed to reach 
threshold for the asymptomatic group was greater than the time required by 
symptomatic patients to obtain tolerance levels (Fig. 3B). The corresponding tcp0, 
values were lower at threshold in the asymptomatic group than at tolerance level for 
the symptomatic group (Fig. 3A). 
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Fig. 2. Time course of mean values of tcp0, (upper traces) and heart rate (lower traces) for symptomatic 
(dashed lines; n = 6) and asymptomatic (solid lines; n = 6) patients. Time of cuff inflation denoted by 
arrows. Threshold and tolerance levels are depicted separately (arrows) for symptomatic and asymptomatic 
groups. 
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Fig. 3. A: group differences in tcpOa at threshold and tolerance levels. Mean values are depicted for 
(n = 6) symptomatic patients by blank columns and those for (n = 6) asymptomatic patients by hatched 
columns. Error bars show + 1 SE. Significance levels are shown for I tests. B: group differences in time 
needed to reach threshold and tolerance levels for symptomatic (n = 6) and asymptomatic (n = 6) 
patients. Significance levels are shown for t tests. 
Significant differences in threshold were exhibited between the symptomatic and 
asymptomatic groups on the electrical pain test. Results are depicted in Fig. 4. As 
can be seen in the figure, symptomatic patients showed a mean threshold of 0.55 
mA, which is in good agreement with Noterman’s original findings [22]. In contrast, 
asymptomatic patients demonstrated a significantly higher mean threshold of 1.0 
mA. Results of a t test on group differences for the mean threshold value were 
00 
00 
SYMPTCWATIC ASYMPTOMATIC 
Fig. 4. Mean values + 1 SE. and distribution of individual values on the electrical pain test according to 
the Notermans procedure for symptomatic (0) and asymptomatic (0) groups. Significance levels are 
shown for I tests. 
w$JY significant (t = 7.81, u”= 58, P < 0.005). Skin resistance had no significant 
effect on threshold levels. 
Experiment 4 
Following naloxone injection, no differences were evident in parameters of 
exercise ECG, neither in ma~mum effort, m~mum heart rate, ma~mum blood 
pressure, nor in ST segment depression in asymptomatic patients. Only in 2 of our 
10 asymptomatic patients could angina pectoris be provoked after naloxone injec- 
tion, although they had never previously experienced such symptoms during exercise 
testing. In 1 patient the effect of naloxone was dose dependent. After 2 mg of 
naloxone, angina pectoris occurred at 75 W, 2 min and increased at 75 W, 4 min. 
After 4 mg of naloxone, the patient reported typical angina pectoris at 50 W and at 
75 W the exercise test was discontinued due to severe angina. These findings were 
replicated after a 2 month period. This patient had a l-vessel disease without 
infarction and was totally asymptomatic. The other asymptomatic patient in whom 
angina pectoris could be provoked during exercise ECG had a 2-vessel disease and 
an inferior infarction. Although the other asymptomatic patient did report pain 
during exercise after naloxone injection, his pain did not increase by continuing 
exercise. 
Discussion 
The findings of the experiments presented here indicate that significant and 
replicable differences in threshold and tolerance levels for experimentally induced 
pain exist between symptomatic and asymptomatic myocardial ischemia patients, 
asymptomatic patients showing a general hyposensitivity to nociceptive stimulation. 
Earlier clinical reports of patients with painless myocardial infarction 11,241 suggest 
that these patients have an unusually low sensibility to pain. However, these earlier 
findings were only partly quantified [19]. Keele [17] and Procacci et al. [23] reported 
higher pain thresholds in patients with silent myocardial infarction. The observation 
that, in most of our asymptomatic patients, asymptomatic ischemia was reproduci- 
ble over a number of examinations and was evident in daily life and during 
infarction itself speaks for a more person-related rather than a situation-dependent 
cause. Note, however, that there is considerable within-group variance (Figs. 1 and 
4). It appears, therefore, that other factors may be involved in asymptomatic 
myocardial ischemia. 
It has been argued that dest~ct~on of pain pathways following myocardial 
infarction, diffuse coronary heart disease, or polyneuropathy may be responsible for 
asymptomatic myocardial ischemia. This argument appears, however, not likely to 
apply to our patients. Symptomatic and asymptomatic patients showed no dif- 
ferences on history of prior infarction, number and degree of diseased coronary 
vessels, history of alcohol consumption or diabetes. 
Other authors [11,14,25] have argued that patients with asymptomatic myocardial 
ischemia may exhibit lower tissue oxygen demands and thus do not obtain the levels 
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of &hernia during exercise that symptomatic patients do. This argument does not 
hold for our patients because: (1) ST segment depression was greater in our 
asymptomatic patients (as seen in Table II) and (2) no mean difference was found 
between the rate of residual oxygen metabolism (as indicated by the rate of decrease 
in tcpq) in the working forearm following arterial occlusion. This lack of dif- 
ferences is evident in the initial tcpq values and the mean slope (representing 0, 
decrement rate) to the point of cuff deflation (see Fig, 2). As is evident in that 
figure, asymptomatics worked longer thus creating greater levels of anoxia before 
pain was perceived. 
Our results rather suggest that cardiac pain is influenced by an extracardiac, 
pain-regulating factor, which may inhibit nociceptive pathways either at the dorsal 
root or higher up in the central nervous system. The observation that in some 
asymptomatic patients angina pectoris could be provoked following naioxone, but 
not following placebo, support a possible role of opioid mechanisms. 
Janal et al. 1161 showed that endogenous opioid mechanisms are specifically 
involved in the modification of deep somatic pain, similar to ischemic pain. Moore 
et al. [21] and Lewis et al. [18] found substantial interindividual differences in 
sensitivity to ischemic pain. In addition, Yanagida [28] and Willer et al. [27] showed 
that congenital insensitivity to other forms of clinical pain in single cases can be 
reversed by m~ium-to-large doses of naloxone. The results of Buchsbaum and 
coworkers [2,3] suggest that varying concentrations of endorphins in plasma and 
cerebrospinal fluid or varying amounts of endorphins in intersynaptic fluid may 
represent a chemical substrate of individual differences in pain sensitivity. 
Most of the asymptomatic patients tested here reported no pain following 
injection of 2 mg naloxone. Although substantial, angina pectoris could be provoked 
in only 2 of 10 asymptomatic patients tested in exercise ECG following naloxone 
injection. These single observations are, therefore, not sufficient to support a 
relationship between myocardial ischemia and endorphins. Han 1131 has, however, 
recently argued that not all opioid-dependent analgesic mechanisms can be in- 
fluenced by low-to-moderate doses of naloxone as those used here. Other factors 
may be involved in this di~nished sensitivity to pain in patients with asymptomatic 
myocardial ischemia, for example, non-opioid pain regulating mechanisms. Further 
research should also consider the role of cognitive processes that define the presence 
or absence of ischemic pain [9]. Basic biochemical (e.g., arachidonic acid metabo- 
lites) and mechanical factors involved in coronary pain [7,8], also remain unclear. 
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